Location: Home
  • search
  • go
  • Relate News
  • 2/27/2025Biokin (SystImmune) Initiates First Autoimmune Clinical Trial for Tetr...
  • 2/27/2025Akeso Initiates First-in-Human Phase 1 Trial for HER3-Targeting ADC AK...
  • 2/27/2025Novartis' NDA for BTK Inhibitor Remibrutinib Accepted by NMPA
  • 2/27/2025Takeda Expands Partnership with BridGene to Tackle Hard-to-Drug Target...
  • 2/26/2025In Vivo Gene Editing Product ART002 Achieves Saturation of Pharmacolog...
  • 2/26/2025Former NMPA Deputy Commissioner Under Investigation
  • 2/26/2025YolTech Therapeutics Announces Positive Clinical Data for In Vivo Gene...
  • 2/26/2025Hengrui Reports Promising Results for Trastuzumab Rezetecan in HER2-Mu...
  • 2/26/2025Chinese Biotech Firms Cash in on Promising Drug Discoveries via Licens...
  • 2/25/2025XellSmart Secures Second FDA IND Approval for iPSC-Derived ALS Therapy...
  • 2/25/2025Innovent's Dual Immunotherapy for Colon Cancer Advances with NMPA Prio...
  • 2/25/2025Pfizer to Study China-Originated Ivonescimab in ADC Combo Under Summit...
  • 2/25/2025OS Therapies Launches Subsidiary to Seek ADC Joint Ventures in US and ...
  • 2/25/2025China Launches Flagship Hospital Alliance to Advance Integrative Medic...
  • 2/25/2025Ardelyx/Fosun'sTenapanor Approved for Hyperphosphatemia in CKD Dialysi...
  • 2/25/2025BioCity's SC0062 Achieves Primary Endpoint in Phase 2 DKD Trial
  • 2/21/2025FibroGen Sells China Subsidiary to AstraZeneca in $160 Million Deal
  • 2/21/2025China Unveils 2025 Action Plan to Boost Foreign Investment in Biotech ...
  • 2/21/2025India Can Surpass China in Drug Discovery, Says Biocon Chief
  • 2/21/2025Novo Nordisk Sues KBP Biosciences for $830 Million Over Alleged Fraud
  • 2/21/2025NMPA Announces Package Insert Revision of Fluorouracil Injection
  • 2/21/2025MediLink's YL217 Received FDA Clearance of IND Application
  • 2/21/2025Hengrui Medicine Advances Dual GLP-1/GIP Agonist HRS9531 with First Ph...
  • 2/21/2025Recent Executive Moves
  • 2/21/2025Lessons from China's 2024 National Negotiation of Drug Prices (GT)
  • 2/20/2025Ascletis Reports Positive Interim Results from U.S. Phase Ib Study of ...
  • 2/20/2025Chimigen Secures CNY100M+ in Pre-A Financing to Advance Cancer and Hep...
  • 2/19/2025CSPC Pharma Partners with Radiance for Global Development of Anticance...
  • 2/19/2025Pharma Industry Faces Uncertainty Amid Potential U.S. Tariffs on Chin...
  • 2/19/2025Genuine Biotech Submits Second IPO Application amid Hong Kong Market R...
  • Page:9/761 Total number of articles:22823: [First][<<] [7] [8] [9] [10] [11] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group